CollabRx Partners with Sengenics for Molecular Diagnostics

[at noodls] – San Francisco, Calif., April 9, 2013 – CollabRx, Inc. (NASDAQ: CLRX), today announced a partnership with Sengenics, a leading genetic diagnostics company, to provide turn-key diagnostic decision making … more

View todays social media effects on CLRX

View the latest stocks trending across Twitter. Click to view dashboard

See who CollabRx is hiring next, click here to view